News Briefs: Centene Completes Acquisition of Magellan Health | Jan. 6, 2022

Centene Corp. completed its $2.2 billion acquisition of Magellan Health, Inc. The previously announced deal will allow Centene to expand its behavioral health platform, increase its specialty health and pharmacy capabilities, and enhance its ability to address members’ whole health. Magellan Health will operate independently under Centene’s Health Care Enterprises umbrella, with CEO Ken Fasola and other members of Magellan Health’s leadership team continuing to lead the organization, Centene said on Jan. 4.

© 2022 MMIT
Lauren Flynn Kelly

Lauren Flynn Kelly Managing Editor, Radar on Medicare Advantage

Lauren has been covering health business issues, including drug benefits and specialty pharmacy, for more than a decade. She served as editor of Drug Benefit News (the predecessor to Radar on Drug Benefits) from 2004 to 2005 and again from 2011 to 2016, and now manages Radar on Medicare Advantage. Lauren graduated from Vassar College with a B.A. in English.

Related Posts

magnifying-glass
December 1

KHN Report Underscores Looming Issue of Extrapolation, FFS Errors in RADV Audits

READ MORE
audit-report
December 1

OIG Audits Add to Debate Over Extrapolation in Recovering MA Overpayments

READ MORE
businessman-viewing-news-update-journalism-headline-on-a-laptop
December 1

News Briefs: For 2023, UnitedHealth Group Expects Its Overall Medicare Advantage Enrollment to Jump 9%

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today